Stay updated on Ipilimumab+Nivolumab for Stage IV IBC Clinical Trial

Sign up to get notified when there's something new on the Ipilimumab+Nivolumab for Stage IV IBC Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Ipilimumab+Nivolumab for Stage IV IBC Clinical Trial page

  1. Check
    5 days ago
    No Change Detected
  2. Check
    12 days ago
    No Change Detected
  3. Check
    19 days ago
    Change Detected
    Summary
    The MeSH term 'Inflammatory breast carcinoma' was added. A new resources entry for the Genetic and Rare Diseases Information Center was added, and the page revision was updated from v3.4.3 to v3.5.0.
    Difference
    0.2%
    Check dated 2026-03-18T17:41:40.000Z thumbnail image
  4. Check
    26 days ago
    Change Detected
    Summary
    Added Revision: v3.4.3 and removed Revision: v3.4.2.
    Difference
    0.0%
    Check dated 2026-03-11T15:43:33.000Z thumbnail image
  5. Check
    47 days ago
    Change Detected
    Summary
    No significant additions or deletions were detected; the page content and layout appear unchanged.
    Difference
    0.0%
    Check dated 2026-02-18T07:13:13.000Z thumbnail image
  6. Check
    55 days ago
    Change Detected
    Summary
    Revision: v3.4.2 was added; the lapse-in-government-funding notice and Revision: v3.4.1 were removed. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.4%
    Check dated 2026-02-11T05:56:28.000Z thumbnail image
  7. Check
    62 days ago
    Change Detected
    Summary
    Added a site-wide funding-status notice and updated the page revision from v3.4.0 to v3.4.1.
    Difference
    0.4%
    Check dated 2026-02-04T04:26:32.000Z thumbnail image
  8. Check
    69 days ago
    Change Detected
    Summary
    The page now includes a glossary toggle, adds a 'Last Update Submitted that Met QC Criteria' label, normalizes 'No FEAR Act Data' to 'No FEAR Act data', and updates the revision footer to v3.4.0.
    Difference
    0.2%
    Check dated 2026-01-28T00:44:40.000Z thumbnail image

Stay in the know with updates to Ipilimumab+Nivolumab for Stage IV IBC Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Ipilimumab+Nivolumab for Stage IV IBC Clinical Trial page.